These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 16221840)

  • 1. Functional correction of CNS phenotypes in a lysosomal storage disease model using adeno-associated virus type 4 vectors.
    Liu G; Martins I; Wemmie JA; Chiorini JA; Davidson BL
    J Neurosci; 2005 Oct; 25(41):9321-7. PubMed ID: 16221840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional correction of established central nervous system deficits in an animal model of lysosomal storage disease with feline immunodeficiency virus-based vectors.
    Brooks AI; Stein CS; Hughes SM; Heth J; McCray PM; Sauter SL; Johnston JC; Cory-Slechta DA; Federoff HJ; Davidson BL
    Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6216-21. PubMed ID: 11959904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant adeno-associated virus-mediated correction of lysosomal storage within the central nervous system of the adult mucopolysaccharidosis type VII mouse.
    Sferra TJ; Qu G; McNeely D; Rennard R; Clark KR; Lo WD; Johnson PR
    Hum Gene Ther; 2000 Mar; 11(4):507-19. PubMed ID: 10724030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systemic hyperosmolality improves beta-glucuronidase distribution and pathology in murine MPS VII brain following intraventricular gene transfer.
    Ghodsi A; Stein C; Derksen T; Martins I; Anderson RD; Davidson BL
    Exp Neurol; 1999 Nov; 160(1):109-16. PubMed ID: 10630195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic correction of the fetal brain increases the lifespan of mice with the severe multisystemic disease mucopolysaccharidosis type VII.
    Karolewski BA; Wolfe JH
    Mol Ther; 2006 Jul; 14(1):14-24. PubMed ID: 16624622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adeno-associated virus type 5 reduces learning deficits and restores glutamate receptor subunit levels in MPS VII mice CNS.
    Liu G; Chen YH; He X; Martins I; Heth JA; Chiorini JA; Davidson BL
    Mol Ther; 2007 Feb; 15(2):242-7. PubMed ID: 17235300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease.
    Vogler C; Sands MS; Galvin N; Levy B; Thorpe C; Barker J; Sly WS
    J Inherit Metab Dis; 1998 Aug; 21(5):575-86. PubMed ID: 9728337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS-directed gene therapy for lysosomal storage diseases.
    Sands MS; Haskins ME
    Acta Paediatr; 2008 Apr; 97(457):22-7. PubMed ID: 18339183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extensive beta-glucuronidase activity in murine central nervous system after adenovirus-mediated gene transfer to brain.
    Ghodsi A; Stein C; Derksen T; Yang G; Anderson RD; Davidson BL
    Hum Gene Ther; 1998 Nov; 9(16):2331-40. PubMed ID: 9829532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.
    Hennig AK; Levy B; Ogilvie JM; Vogler CA; Galvin N; Bassnett S; Sands MS
    J Neurosci; 2003 Apr; 23(8):3302-7. PubMed ID: 12716937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained production of beta-glucuronidase from localized sites after AAV vector gene transfer results in widespread distribution of enzyme and reversal of lysosomal storage lesions in a large volume of brain in mucopolysaccharidosis VII mice.
    Skorupa AF; Fisher KJ; Wilson JM; Parente MK; Wolfe JH
    Exp Neurol; 1999 Nov; 160(1):17-27. PubMed ID: 10630187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular signatures of disease brain endothelia provide new sites for CNS-directed enzyme therapy.
    Chen YH; Chang M; Davidson BL
    Nat Med; 2009 Oct; 15(10):1215-8. PubMed ID: 19749771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-deficient mice.
    Passini MA; Watson DJ; Vite CH; Landsburg DJ; Feigenbaum AL; Wolfe JH
    J Virol; 2003 Jun; 77(12):7034-40. PubMed ID: 12768022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.
    Bosch A; Perret E; Desmaris N; Heard JM
    Mol Ther; 2000 Jan; 1(1):63-70. PubMed ID: 10933913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delivery of an Adeno-Associated Virus Vector into Cerebrospinal Fluid Attenuates Central Nervous System Disease in Mucopolysaccharidosis Type II Mice.
    Hinderer C; Katz N; Louboutin JP; Bell P; Yu H; Nayal M; Kozarsky K; O'Brien WT; Goode T; Wilson JM
    Hum Gene Ther; 2016 Nov; 27(11):906-915. PubMed ID: 27510804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse.
    Sferra TJ; Backstrom K; Wang C; Rennard R; Miller M; Hu Y
    Mol Ther; 2004 Sep; 10(3):478-91. PubMed ID: 15336648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neonatal gene transfer leads to widespread correction of pathology in a murine model of lysosomal storage disease.
    Daly TM; Vogler C; Levy B; Haskins ME; Sands MS
    Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2296-300. PubMed ID: 10051635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neonatal intramuscular injection with recombinant adeno-associated virus results in prolonged beta-glucuronidase expression in situ and correction of liver pathology in mucopolysaccharidosis type VII mice.
    Daly TM; Okuyama T; Vogler C; Haskins ME; Muzyczka N; Sands MS
    Hum Gene Ther; 1999 Jan; 10(1):85-94. PubMed ID: 10022533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.
    Roca C; Motas S; Marcó S; Ribera A; Sánchez V; Sánchez X; Bertolin J; León X; Pérez J; Garcia M; Villacampa P; Ruberte J; Pujol A; Haurigot V; Bosch F
    Hum Mol Genet; 2017 Apr; 26(8):1535-1551. PubMed ID: 28334745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.
    Frisella WA; O'Connor LH; Vogler CA; Roberts M; Walkley S; Levy B; Daly TM; Sands MS
    Mol Ther; 2001 Mar; 3(3):351-8. PubMed ID: 11273777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.